Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%

Belfast Health and Social Care Trust

This public procurement record has 4 releases in its history.

ContractTermination

08 Oct 2026 at 14:34

UK11 - Contract Termination Notice
Award

10 Oct 2025 at 11:45

UK7 - Contract Details Notice
Award

22 Sep 2025 at 14:20

UK6 - Contract Award Notice
Award

22 Sep 2025 at 14:15

UK5 - Transparency Notice
Summary of the contracting process

Belfast Health & Social Care Trust procured HyQvia 10%, a human normal immunoglobulin medicine supplied through a homecare service. The requirement is for the medicine and its homecare provision, supporting continuity of patient care. This is a pharmaceutical supply contract rather than a general homecare or clinical services opportunity. Delivery is in the United Kingdom; the buyer is based in Belfast. The product is identified as a pharmaceutical product (CPV 33600000). The procurement was structured as one lot and awarded to a single supplier. The stated rationale was that the medicine was essential to maintain continuity of care and available only from one economic operator, with the Trust stating that competition had not been artificially narrowed.

The procurement is complete and the contract was awarded directly to HealthNet Homecare (UK) Limited. The award was made on 22 September 2025, with a value of £1,410,000. The contract was signed on 9 October 2025 and was scheduled to run from 9 October 2025 to 30 September 2027. The contract was terminated on 24 September 2026; the termination classification is recorded as “other”, with no further reason stated. The procurement used a direct award because the Trust considered the medicine available from only one economic operator and necessary for continuity of patient care. There was one lot, and the published rationale indicates that competition was not artificially restricted. No scored evaluation criteria are described.

For suppliers seeking comparable work with Belfast Health & Social Care Trust, this award demonstrates demand for a specific specialist immunoglobulin medicine supplied through homecare, at substantial scale and over a multi-year term. A credible provider would need access to the required branded product, the ability to supply it reliably, and the operational capability to support home delivery for patients. The stated reason for selecting a single operator was product availability, rather than a general competition based on price or service scoring. Suppliers should therefore be able to evidence authorised access to the medicine and dependable supply continuity, alongside effective homecare fulfilment. The award indicates that the Trust treats uninterrupted availability of essential medicines as central to patient care; experience delivering this exact product and service model would be particularly relevant.

How relevant is this notice?

Notice Information

Notice Title

IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%

Notice Description

Procurement of IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%.

Procurement Information

These essential medicines are required for continuity of patient care. These medicines are available only from one economic operator. BHSCT can confirm that the absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-059f24
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/095273-2026
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
UK11 - Contract Termination Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Direct
Procurement Method Details
Direct award
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
£1,410,000 £1M-£10M
Contracts Value
£1,410,000 £1M-£10M

Notice Dates

Publication Date
8 Oct 20262 weeks ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
22 Sep 20251 years ago
Contract Period
9 Oct 2025 - 30 Sep 2027 1-2 years
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Active
Contracts Status
Terminated

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
Belfast Health and Social Care Trust
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
BELFAST
Postcode
BT12 6BA
Postcode Area
Northern Ireland
Country
Northern Ireland
Major Region (ITL 1)
TLN Northern Ireland
Basic Region (ITL 2)
TLN0 Northern Ireland
Small Region (ITL 3)
TLN06 Belfast
Delivery Location
Not specified
Local Authority
Belfast
Electoral Ward
Falls
Westminster Constituency
Belfast West

Supplier Information

Number of Suppliers
1
Supplier Name

HealthNet Homecare (UK) Limited

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...